Graduate Programs in Biomedical Sciences
The Saint Louis University Graduate Programs in Biomedical Sciences is made up of three programs: Biochemistry and Molecular Biology; Molecular Microbiology and Immunology; and Pharmacology and Physiology.
- Biochemistry and Molecular Biology
- Molecular Microbiology and Immunology
- Pharmacological and Physiological Sciences
First-year courses focus on the basic biochemical, molecular, cellular and organismal aspects of the biomedical sciences, preparing you for more intensive, individualized instruction that will be unique to the discipline you choose to study in the following years.
Instructors come from all three Ph.D. programs. Their charge is to introduce you to the most recent findings and the methodologies used to study major issues in their fields. Coursework includes didactic lectures, small-group problem-solving sessions, student presentations and hands-on research experience.
Active seminars in all departments and programs provide broad exposure to the wide scope of biomedical research and introduce you to potential future employers or collaborators. We emphasize the preparation of technically skilled and thoughtful scientists for diverse careers in academia, industry or government.
Diversity
The Saint Louis University School of Medicine is committed to the importance of diversity. We seek to immerse our graduate and medical students in a training atmosphere that prepares them for the practice of medicine in a multicultural America. We strive to demonstrate this inclusiveness in the classroom and in all areas of our admissions practices, academic advising, student services and activities, curricular offerings and administrative policies. Our goal is to produce well-rounded and culturally competent professionals who will respectfully serve their diverse communities.
The Office of Diversity, Equity and Inclusion oversees the School of Medicine’s efforts to promote inclusion for the graduate and medical school community. Programs, events and initiatives are designed to raise awareness, inspire action, support equitable employment and cultivate a culture of diversity and inclusion.
Visit the Office of Diversity, Equity and Inclusion
Applications and Financial Aid
You must complete both the classified graduate school application and the graduate program in biomedical sciences application to be considered for our Ph.D. programs.
SLU Graduate School Application
Email the completed application for the Graduate Program in Biomedical Sciences to Katherine Kornuta at katherine.kornuta@health.slu.edu.
Financial aid is available, and all first- and second-year students receive a nationally competitive student stipend, as well as tuition waivers and health insurance. Stipends, health benefits and tuition costs are the responsibility of your advisor or doctoral program during the final years of your graduate study and are most commonly provided by research grants or contracts.
Colloquiums
The biomedical sciences colloquiums are scheduled every Wednesday at noon. Unless otherwise announced, all colloquium sessions will be held in Auditorium B of the Learning Resource Center.
CORE Graduate Program Colloquiums Schedule
| Date | Presenter | Paper |
|---|---|---|
| Sept. 25, 2024 | Katie Danforth |
Zou, D., Yin, Z., Yi, S.G. et al. CD4+ T cell immunity is dependent on an intrinsic stem-like program. Nat Immunol 25, 66–76 (2024) |
| Oct. 2, 2024 | Don Ashley Malabana |
Widjaja, A.A., Lim, WW., Viswanathan, S. et al. Inhibition of IL-11 signalling extends mammalian healthspan and lifespan. Nature 632, 157–165 (2024). |
| Oct. 16, 2024 | Jennifer Brown |
George, Dale S et al. “The Mas-related G protein-coupled receptor d (Mrgprd) mediates pain hypersensitivity in painful diabetic neuropathy.” Pain vol. 165,5 (2024) |
| Oct. 23, 2024 | Capri Charleston |
Olešová, D., Dobešová, D., Majerová, P. et al. Changes in lipid metabolism track with the progression of neurofibrillary pathology in tauopathies. J Neuroinflammation 21, 78 (2024) |
| Nov. 6, 2024 | Hanaa Saleh |
Raj, V Stalin et al. “Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.” Nature vol. 495,7440 (2013) |
| Nov. 13, 2024 | Spencer Jones |
Sun Ryu, Xuemei Liu, Tingting Guo, Zhaohua Guo, Jintao Zhang, Yu-Qing Cao, Peripheral CCL2-CCR2 signalling contributes to chronic headache-related sensitization. Brain, Volume 146, Issue 10, October 2023 |
All students, staff and faculty are encouraged to attend. The schedule for the spring semester is distributed in December. There are 11 presentations by the first-year core students, leaving some open dates for volunteers. Any faculty member, post-doctoral fellow or senior graduate student who would like to present in the spring should contact Willis K. Samson, Ph.D. at willis.samson@health.slu.edu.